Biosyent Inc
Open
$14.61
Prev. Close
$14.60
High
$14.61
Low
$14.61
Market Snapshot
$113.56M
18.5
0.75
$42.18M
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.
emptyResult
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.
Recently from Cashu
BioSyent Inc. Reports 25% Revenue Growth and Strategic Global Expansion Initiatives
BioSyent Inc. Reports Strong Financial Growth and Strategic Expansion Initiatives In its recent Q4 and Fiscal Year 2024 Earnings Call, BioSyent Inc. showcases a robust financial performance under the…
Biosyent Inc. Reports Strong Q1 Growth Driven by FeraMAX® and Tibella® Sales Increases
Biosyent Inc. Delivers Strong Q1 Results with Notable Product Growth Biosyent Inc. showcases impressive growth in its first quarter financial results for 2025, which ended on March 31. The company, a…
BioSyent Inc. Set to Release First-Quarter Earnings on May 15, 2025
### BioSyent Inc. Prepares for First-Quarter Earnings Release BioSyent Inc., a specialty pharmaceutical company headquartered in Mississauga, Ontario, prepares to release its first-quarter earnings on…
BioSyent Inc. Prepares for Innovation Showcase at Planet MicroCap Conference 2025
BioSyent Inc. Sets Stage for Innovation at Upcoming Investor Conference BioSyent Inc., a Mississauga-based specialty pharmaceutical company, gears up for a significant presence at the Planet MicroCap…